Analyzing AMN Healthcare Services (NYSE:AMN) and Mangoceuticals (NASDAQ:MGRX)

AMN Healthcare Services (NYSE:AMN) and Mangoceuticals (NASDAQ:MGRX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, valuation and earnings.

Valuation & Earnings

This table compares AMN Healthcare Services and Mangoceuticals”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$3.52 billion	0.42	-$95.70 million	$2.75	13.79
Mangoceuticals	$315,227.00	13.62	-$20.64 million	($1.01)	-0.20

Mangoceuticals has lower revenue, but higher earnings than AMN Healthcare Services. Mangoceuticals is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current recommendations for AMN Healthcare Services and Mangoceuticals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	1	4	4	0	2.33
Mangoceuticals	1	0	0	0	1.00

AMN Healthcare Services presently has a consensus price target of $39.17, indicating a potential upside of 3.25%. Given AMN Healthcare Services’ stronger consensus rating and higher possible upside, analysts clearly believe AMN Healthcare Services is more favorable than Mangoceuticals.

Risk & Volatility

AMN Healthcare Services has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 2.15, meaning that its stock price is 115% more volatile than the S&P 500.

Profitability

This table compares AMN Healthcare Services and Mangoceuticals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.10%	23.42%	7.19%
Mangoceuticals	-4,794.60%	-96.39%	-89.60%

Insider & Institutional Ownership

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by insiders. Comparatively, 16.0% of Mangoceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

AMN Healthcare Services beats Mangoceuticals on 10 of the 14 factors compared between the two stocks.

About AMN Healthcare Services

AMN Healthcare Services, Inc. is a healthcare workforce solutions company that helps healthcare organizations recruit and manage clinical and nonclinical staff. Its clients include hospitals, health systems, physician groups and other care providers. The company’s services include temporary and permanent staffing for nurses, physicians and allied healthcare professionals; locum tenens staffing; and workforce management programs. AMN also provides language interpretation and related services, as well as technology and consulting solutions to support workforce planning and recruitment.

About Mangoceuticals

Mangoceuticals, Inc., doing business as MangoRx, is a men’s health and wellness company that operates a direct-to-consumer telehealth platform. The company provides online access to healthcare consultations, prescription treatments and related products designed to address common men’s health concerns. Its offerings have included treatments for erectile dysfunction and hair loss, as well as other wellness categories such as testosterone support and weight management. Products are generally marketed through the company’s digital platform and may be provided through prescriptions issued by independent licensed healthcare professionals, where appropriate.